David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...

The Trump administration has resumed collection efforts on student loans, affecting those in default sooner than expected.

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, ...

Company to host conference call and webcast today at 8:00 a.m. ET--MIAMI, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Veru Inc.

MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is in three ongoing VESPER Phase 2b trials, with data from VESPER-1 expected in mid-2025 MET-233i, a monthly, ultra-long ac ...

Q2 2025 Results Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsSam Fisch - Executive Director, Investor Relations ...

This positions us to collect longer-term data on safety tolerability and efficacy both as Monotherapy and in combination with GLP-1 ... with ECO next week and ADA in June. Clinically we are ...

President Donald Trump on Monday signed an executive order asking drugmakers to voluntarily reduce the prices of key ...

Eli Lilly announced that its obesity therapy Zepbound delivered superior outcomes versus Novo Nordisk’s Wegovy across five ...